A repeat biopsy confirmed AITL with wild-type TP53 and no copy number alterations at TP53, MDM2, or MDMX. She was started on ALRN-6924 given weekly for 3 weeks out of 4. This evidence concerns the gene MDM2 and angioimmunoblastic T-cell lymphoma.